Alvotech to participate in jefferies healthcare conference in new york, june 5-6, 2024

Reykjavik, iceland, may 29, 2024 (globe newswire) -- alvotech (nasdaq: alvo), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the jefferies healthcare conference in new york on june 5-6, 2024. alvotech will present and host investor and business meetings at the conference.
ALVO Ratings Summary
ALVO Quant Ranking